Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Snelling

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Bio-Protocol|November 27, 2024
Measurement of the Activity of Wildtype and Disease-Causing ALPK1 Mutants in Transfected Cells With a 96-Well Format NF-κB/AP-1 Reporter AssayTom Snelling
Bio-Protocol|November 27, 2024
Quantitative Measurement of the Kinase Activity of Wildtype ALPK1 and Disease-Causing ALPK1 Mutants Using Cell-Free Radiometric Phosphorylation AssaysTom Snelling
Trends in Biochemical Sciences|November 23, 2024
Diseases caused by altered specificity of a protein kinase for its allosteric activatorsPhilip Cohen, Tom Snelling
Pharmacy Practice|October 9, 2019
Agreement between units of measure for paediatric antibiotic utilisation surveillance using hospital pharmacy supply dataMona Mostaghim, Tom Snelling, Beata Bajorek
BMJ Open Respiratory Research|July 16, 2021
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physiciansGrace Currie, Anna Tai, Tom Snelling, et al.
Pharmacy Practice|July 20, 2018
Paediatric antimicrobial stewardship and safe prescribing: an assessment of medical staff knowledge and behaviourMona Mostaghim, Tom Snelling, Hala Katf, et al.
Orphanet Journal of Rare Diseases|July 14, 2019
RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic frameworkMatthew I Bellgard, Tom Snelling, James M McGree
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2023
ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugarsTom Snelling, Anton Saalfrank, Nicola T Wood, et al.
Glycobiology|December 28, 2018
Absence of a human ortholog of rodent Kupffer cell galactose-binding receptor encoded by the CLEC4f geneMaureen E Taylor, Tom Snelling, David F Smith, et al.
The Biochemical Journal|September 13, 2022
Co-ordinated control of the ADP-heptose/ALPK1 signalling network by the E3 ligases TRAF6, TRAF2/c-IAP1 and LUBACTom Snelling, Natalia Shpiro, Robert Gourlay, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Bio-Protocol|November 27, 2024
Measurement of the Activity of Wildtype and Disease-Causing ALPK1 Mutants in Transfected Cells With a 96-Well Format NF-κB/AP-1 Reporter AssayTom Snelling
Bio-Protocol|November 27, 2024
Quantitative Measurement of the Kinase Activity of Wildtype ALPK1 and Disease-Causing ALPK1 Mutants Using Cell-Free Radiometric Phosphorylation AssaysTom Snelling
Trends in Biochemical Sciences|November 23, 2024
Diseases caused by altered specificity of a protein kinase for its allosteric activatorsPhilip Cohen, Tom Snelling
Pharmacy Practice|October 9, 2019
Agreement between units of measure for paediatric antibiotic utilisation surveillance using hospital pharmacy supply dataMona Mostaghim, Tom Snelling, Beata Bajorek
BMJ Open Respiratory Research|July 16, 2021
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physiciansGrace Currie, Anna Tai, Tom Snelling, et al.
Pharmacy Practice|July 20, 2018
Paediatric antimicrobial stewardship and safe prescribing: an assessment of medical staff knowledge and behaviourMona Mostaghim, Tom Snelling, Hala Katf, et al.
Orphanet Journal of Rare Diseases|July 14, 2019
RD-RAP: beyond rare disease patient registries, devising a comprehensive data and analytic frameworkMatthew I Bellgard, Tom Snelling, James M McGree
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2023
ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugarsTom Snelling, Anton Saalfrank, Nicola T Wood, et al.
Glycobiology|December 28, 2018
Absence of a human ortholog of rodent Kupffer cell galactose-binding receptor encoded by the CLEC4f geneMaureen E Taylor, Tom Snelling, David F Smith, et al.
The Biochemical Journal|September 13, 2022
Co-ordinated control of the ADP-heptose/ALPK1 signalling network by the E3 ligases TRAF6, TRAF2/c-IAP1 and LUBACTom Snelling, Natalia Shpiro, Robert Gourlay, et al.
Pageof 8